1. Home
  2. UTHR vs VRSN Comparison

UTHR vs VRSN Comparison

Compare UTHR & VRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • VRSN
  • Stock Information
  • Founded
  • UTHR 1996
  • VRSN 1995
  • Country
  • UTHR United States
  • VRSN United States
  • Employees
  • UTHR N/A
  • VRSN N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • VRSN EDP Services
  • Sector
  • UTHR Health Care
  • VRSN Technology
  • Exchange
  • UTHR Nasdaq
  • VRSN Nasdaq
  • Market Cap
  • UTHR 15.5B
  • VRSN 17.0B
  • IPO Year
  • UTHR 1999
  • VRSN 1998
  • Fundamental
  • Price
  • UTHR $364.11
  • VRSN $181.93
  • Analyst Decision
  • UTHR Buy
  • VRSN Buy
  • Analyst Count
  • UTHR 14
  • VRSN 2
  • Target Price
  • UTHR $370.86
  • VRSN $218.00
  • AVG Volume (30 Days)
  • UTHR 371.2K
  • VRSN 656.3K
  • Earning Date
  • UTHR 10-30-2024
  • VRSN 10-24-2024
  • Dividend Yield
  • UTHR N/A
  • VRSN N/A
  • EPS Growth
  • UTHR 25.10
  • VRSN 22.71
  • EPS
  • UTHR 22.72
  • VRSN 8.60
  • Revenue
  • UTHR $2,756,200,000.00
  • VRSN $1,542,400,000.00
  • Revenue This Year
  • UTHR $26.32
  • VRSN $6.42
  • Revenue Next Year
  • UTHR $10.37
  • VRSN $3.46
  • P/E Ratio
  • UTHR $16.00
  • VRSN $20.87
  • Revenue Growth
  • UTHR 25.04
  • VRSN 4.08
  • 52 Week Low
  • UTHR $208.62
  • VRSN $167.05
  • 52 Week High
  • UTHR $417.82
  • VRSN $220.91
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 44.36
  • VRSN 48.72
  • Support Level
  • UTHR $353.65
  • VRSN $176.62
  • Resistance Level
  • UTHR $417.82
  • VRSN $183.28
  • Average True Range (ATR)
  • UTHR 10.93
  • VRSN 2.89
  • MACD
  • UTHR -4.26
  • VRSN -0.09
  • Stochastic Oscillator
  • UTHR 16.30
  • VRSN 52.12

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

About VRSN VeriSign Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Share on Social Networks: